Asia/Oceania

One BioMed was spun out of Singapore's Agency for Science, Technology, and Research to  develop a point-of-care diagnostic platform for infectious disease.

The new list comprises 122 test categories — 46 general IVDs, 69 IVDs for specific diseases, and seven test categories for screening blood donations.

Using a fingerstick, the Mylan HIV Self Test can be completed at home and detects whether HIV antibodies are present in about 15 minutes.

The deal, which is initially for five years, also covers the Eurasian Customs Union, with an option for other countries in the area.

The project, called Seq&Treat, will be implemented in Brazil, China, Georgia, India, and South Africa starting in October.

Seventh Sense Biosystems markets a one-step, push-button device called Tap that uses a microneedle array to collect capillary blood from the arm.

Regulators in the country granted additional approval of the test as a companion diagnostic for Rozlytrek, marketed in Japan by Roche's Chugai Pharmaceutical.

Under the partnership, Heidelberg-based Eluthia will become the primary distributor of BGI's NIFTY noninvasive prenatal test in Germany.

Sonic Healthcare sold its 85 percent stake in GLP. Abbott has acquired the remaining 15 percent interest in the German firm and will collaborate with Sonic in the long term.